Amplification of MYC has been reported in a high percentage of post-radiation angiosarcomas (55-100%)[12-14], being considerably less frequent in angiosarcomas arising in the absence of prior radiation therapy [12, 15]. The gene discussed is MYC; the disease is angiosarcoma.